The pharmacy retail chain said the acquisitions of dozens of locations during the year ended 28 February, and its recent launch of a health insurance offering have helped the group broaden its focus.
"In the two months since launching medical insurance, uptake has exceeded our initial expectations," Dis-Chem said in a statement, although it warned the consumer environment remained "constrained."
Dis-Chem, which runs the second-largest chain of pharmacies in South Africa in competition with Clicks Group, said it administered 1.4 million Covid-19 vaccine doses during the year, resulting in R513m in revenue.
Total revenue climbed 15.7% to R30.4bn. Headline earnings per share, a key metric of profit for South African companies, jumped 27.6% to 99.2 cents for the year.
Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people worldwide every day.
Go to: https://www.reuters.com/
